|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 313.07 USD | -2.29% |
|
-0.23% | +30.45% |
| 06:58am | Cogent Biosciences Expects $547 Million in Net Proceeds From Equity, Convertible Notes Offerings | MT |
| 05:09am | JPMorgan Chase's Kinexys Launches JPM Coin Deposit Token | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 178B | 32.03% | 48.3% | 18% | 1.43% | - | ||
| 102B | 25.03% | 34.43% | 9% | 0.83% | - | ||
| 108B | 46.54% | 69.2% | 9.88% | 0.98% | - | ||
| 99.82B | 45.08% | 69.29% | 10.69% | 0.85% | - | ||
| 82.3B | 22.61% | 33.66% | 11.4% | 1.03% | - | ||
| 65.85B | 34.8% | 49.82% | 13.6% | 0.76% | - | ||
| 86.69B | 37.59% | 62.74% | 9.5% | 0.75% | - | ||
| 41.15B | 27.74% | 42.98% | 15.5% | 0.83% | - | ||
| 18.66B | 35.54% | 54.34% | 13.5% | 0.78% | - | ||
| 19.7B | 40.02% | 59.49% | 14.3% | 1.79% | - | ||
| 32.18B | 38.66% | 33.02% | 9.3% | 0.46% | - | ||
| 64.41B | 20.21% | 58.15% | 13% | 0.76% | - | ||
| 46.24B | 43.96% | 64.24% | 14.49% | 1.28% | - | ||
| 35.98B | 16.58% | 41.87% | 13.6% | 0.68% | - | ||
| 36.73B | 28.34% | 60% | 18.9% | 1.36% | - | ||
| 25.72B | 39.12% | 62.14% | 15.36% | 1.24% | - | ||
| 16.34B | 50.63% | 60.11% | 18% | 1.45% | - | ||
| 28.06B | 31.97% | 57.32% | 13.42% | 0.91% | - | ||
| 8.54B | 61.53% | 75.14% | 17.17% | 2.21% | - | ||
| 27.56B | 28.55% | 41.8% | 8% | 0.57% | - | ||
| Average | 56.15B | 35.33% | 53.9% | 13.33% | 1.05% | ||
| Weighted average by Cap. | 83.87B | 34.53% | 52.38% | 13.41% | 1.06% |
- Stock Market
- Equities
- JPM Stock
- Sector JPMorgan Chase & Co.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
















